MiMedx Stock Forecast - Simple Moving Average

MDXG Stock  USD 5.25  0.01  0.19%   
MiMedx Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of MiMedx's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 27th of January 2026, the RSI of MiMedx's share price is approaching 30. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling MiMedx, making its price go up or down.

Momentum 30

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of MiMedx's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of MiMedx and does not consider all of the tangible or intangible factors available from MiMedx's fundamental data. We analyze noise-free headlines and recent hype associated with MiMedx Group, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting MiMedx's stock price prediction:
Quarterly Earnings Growth
1.138
EPS Estimate Next Quarter
0.085
EPS Estimate Current Year
0.42
EPS Estimate Next Year
0.12
Wall Street Target Price
10.4
Using MiMedx hype-based prediction, you can estimate the value of MiMedx Group from the perspective of MiMedx response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards MiMedx using MiMedx's stock options and short interest. It helps to benchmark the overall future attitude of investors towards MiMedx using crowd psychology based on the activity and movement of MiMedx's stock price.

MiMedx Implied Volatility

    
  1.81  
MiMedx's implied volatility exposes the market's sentiment of MiMedx Group stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if MiMedx's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that MiMedx stock will not fluctuate a lot when MiMedx's options are near their expiration.
The Simple Moving Average forecasted value of MiMedx Group on the next trading day is expected to be 5.25 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.16.

MiMedx after-hype prediction price

    
  USD 5.25  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of MiMedx to cross-verify your projections.

Open Interest Against 2026-03-20 MiMedx Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast MiMedx's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in MiMedx's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for MiMedx stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current MiMedx's open interest, investors have to compare it to MiMedx's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of MiMedx is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in MiMedx. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

MiMedx Additional Predictive Modules

Most predictive techniques to examine MiMedx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MiMedx using various technical indicators. When you analyze MiMedx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A two period moving average forecast for MiMedx is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

MiMedx Simple Moving Average Price Forecast For the 28th of January

Given 90 days horizon, the Simple Moving Average forecasted value of MiMedx Group on the next trading day is expected to be 5.25 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.04, and the sum of the absolute errors of 9.16.
Please note that although there have been many attempts to predict MiMedx Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that MiMedx's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

MiMedx Stock Forecast Pattern

Backtest MiMedx  MiMedx Price Prediction  Buy or Sell Advice  

MiMedx Forecasted Value

In the context of forecasting MiMedx's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. MiMedx's downside and upside margins for the forecasting period are 2.68 and 7.82, respectively. We have considered MiMedx's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
5.25
5.25
Expected Value
7.82
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of MiMedx stock data series using in forecasting. Note that when a statistical model is used to represent MiMedx stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria111.1988
BiasArithmetic mean of the errors 0.0529
MADMean absolute deviation0.1553
MAPEMean absolute percentage error0.0232
SAESum of the absolute errors9.16
The simple moving average model is conceptually a linear regression of the current value of MiMedx Group price series against current and previous (unobserved) value of MiMedx. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for MiMedx

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MiMedx Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.625.257.88
Details
Intrinsic
Valuation
LowRealHigh
3.305.938.56
Details
5 Analysts
Consensus
LowTargetHigh
9.4610.4011.54
Details

MiMedx After-Hype Price Density Analysis

As far as predicting the price of MiMedx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MiMedx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MiMedx, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

MiMedx Estimiated After-Hype Price Volatility

In the context of predicting MiMedx's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MiMedx's historical news coverage. MiMedx's after-hype downside and upside margins for the prediction period are 2.62 and 7.88, respectively. We have considered MiMedx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
5.25
5.25
After-hype Price
7.88
Upside
MiMedx is slightly risky at this time. Analysis and calculation of next after-hype price of MiMedx Group is based on 3 months time horizon.

MiMedx Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as MiMedx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MiMedx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MiMedx, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.49 
2.57
  0.09 
  0.03 
10 Events / Month
7 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
5.25
5.25
0.00 
1,353  
Notes

MiMedx Hype Timeline

MiMedx Group is now traded for 5.25. The entity has historical hype elasticity of -0.09, and average elasticity to hype of competition of 0.03. MiMedx is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at -0.49%. %. The volatility of related hype on MiMedx is about 3835.82%, with the expected price after the next announcement by competition of 5.28. About 72.0% of the company shares are owned by institutional investors. The book value of MiMedx was now reported as 1.61. The company has Price/Earnings To Growth (PEG) ratio of 2.97. MiMedx Group had not issued any dividends in recent years. The entity had 3235:10000 split on the 2nd of April 2008. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days.
Check out Historical Fundamental Analysis of MiMedx to cross-verify your projections.

MiMedx Related Hype Analysis

Having access to credible news sources related to MiMedx's direct competition is more important than ever and may enhance your ability to predict MiMedx's future price movements. Getting to know how MiMedx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MiMedx may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
INVAInnoviva 0.22 9 per month 1.15  0.05  2.16 (2.62) 16.49 
SANASana Biotechnology(0.15)7 per month 0.00 (0.03) 12.59 (8.77) 25.63 
DNTHDianthus Therapeutics(0.31)11 per month 2.41  0.14  8.00 (4.51) 22.10 
NKTRNektar Therapeutics 2.74 10 per month 0.00 (0.15) 6.56 (7.77) 20.31 
ATAIATAI Life Sciences(0.01)8 per month 0.00 (0.17) 5.77 (5.54) 22.95 
RAPPRapport Therapeutics Common(1.88)10 per month 3.95 (0.01) 6.16 (6.77) 16.72 
TSHATaysha Gene Therapies 0.33 10 per month 0.00 (0.02) 7.92 (8.03) 21.14 
INBXInhibrx Biosciences(0.18)9 per month 4.23  0.11  7.03 (6.08) 112.80 
SNDXSyndax Pharmaceuticals 0.08 10 per month 2.34  0.13  8.70 (3.59) 18.37 
CVACCureVac NV(0.17)7 per month 0.00 (0.12) 3.33 (2.80) 18.10 

Other Forecasting Options for MiMedx

For every potential investor in MiMedx, whether a beginner or expert, MiMedx's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. MiMedx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in MiMedx. Basic forecasting techniques help filter out the noise by identifying MiMedx's price trends.

MiMedx Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MiMedx stock to make a market-neutral strategy. Peer analysis of MiMedx could also be used in its relative valuation, which is a method of valuing MiMedx by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

MiMedx Market Strength Events

Market strength indicators help investors to evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MiMedx shares will generate the highest return on investment. By undertsting and applying MiMedx stock market strength indicators, traders can identify MiMedx Group entry and exit signals to maximize returns.

MiMedx Risk Indicators

The analysis of MiMedx's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MiMedx's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mimedx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for MiMedx

The number of cover stories for MiMedx depends on current market conditions and MiMedx's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MiMedx is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MiMedx's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

MiMedx Short Properties

MiMedx's future price predictability will typically decrease when MiMedx's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MiMedx Group often depends not only on the future outlook of the potential MiMedx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MiMedx's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding149 M
Cash And Short Term Investments104.4 M
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of MiMedx to cross-verify your projections.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.138
Earnings Share
0.27
Revenue Per Share
2.668
Quarterly Revenue Growth
0.353
Return On Assets
0.1198
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.